© 1994 British Society for Rheumatology
research-article |
EXPRESSION OF COMPLEMENT REGULATORY MOLECULES AND OTHER SURFACE MARKERS ON NEUTROPHILS FROM SYNOVIAL FLUID AND BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
*Departments of Medical Biochemistry Heath Park, Cardiff CF4 4XN
Departments of Rheumatology, University of Wales College of Medicine Heath Park, Cardiff CF4 4XN
In an effort to elucidate the activation status of neutrophils (PMN) in inflammatory joint disease the expression of relevant cell surface proteins was examined using immunofluorescence and flow cytometry. Paired samples of SF and peripheral blood were obtained from 18 patients with RA and PMN purified using methods designed to minimize activation in vitro. We then used flow cytometry to measure expression of the four membrane complement regulatory molecules, decay accelerating factor (DAF; CD55), complement receptor 1 (CR1; CD35), membrane cofactor protein (MCP; CD46) and CD59; two adhesion molecules of the integrin family LFA1 (
chain, CD11a), complement receptor 3 (CR3; chain, CD11b), and their common ß chain (CD18); the major receptor for immune complexes Fc 
RIII (CD16), and the leucocyte common antigen tyrosine phosphatase (L-CA; CD45). Expression of these molecules was also measured on peripheral blood PMN from 18 age- and sex-matched normal controls. In RA, SF PMN expressed significantly higher levels of the complement regulators CD55 and CD35, the adhesion molecule CR3 (CD11b/CD18) and of CD45 but significantly lower levels of CD46 and CD11a in comparison with blood PMN from the same patient. Expression of CD59 and CD16 did not differ between the two groups. These changes may increase adhesiveness and complement resistance of PMN in SF compared with blood. PMN from RA expressed significantly less of all the complement C3 convertase regulators (CD55, CD46, CD35), all the adhesion molecules (CD11a, CD11b, CD18) and the phosphatase CD45 than did blood PMN from age and sex-matched control individuals.
KEY WORDS: Rheumatoid arthritis, Neutrophils, Complement inhibitors, Activation, Adhesion molecules, Synovial fluid.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Jha, J.-H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU). J. Immunol., June 15, 2006; 176(12): 7221 - 7231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Iking-Konert, B Ostendorf, O Sander, M Jost, C Wagner, L Joosten, M Schneider, and G M Hansch Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells Ann Rheum Dis, October 1, 2005; 64(10): 1436 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I P Crocker, P N Baker, and J Fletcher Neutrophil function in pregnancy and rheumatoid arthritis Ann Rheum Dis, July 1, 2000; 59(7): 555 - 564. [Abstract] [Full Text]
|
|
|
|
|
|
Y. McGrath, G. W. G. Wilkinson, O. B. Spiller, and B. P. Morgan Development of Adenovirus Vectors Encoding Rat Complement Regulators for Use in Therapy in Rodent Models of Inflammatory Diseases J. Immunol., December 15, 1999; 163(12): 6834 - 6840. [Abstract] [Full Text] [PDF]
|
|